75929-243 : Juxtapid 20 mg Oral Capsule


NDC: 75929-243
Labeler: Pharma Packaging Solutions, LLC Dba Tjoapack LLC
Product Type: Human Prescription Drug
Drug Name:  Juxtapid
Dosage Form: Oral Capsule
Application #: NDA203858
Rev. Date: 


NDC Package Codes:

  • 75929-243-14: 28 CAPSULE IN 1 BOTTLE (75929‑243‑14)

Active Ingredients:

  • Lomitapide Mesylate

Dosage Strength:

  • 20 mg

Pharmaceutical Classes:

  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Microsomal Triglyceride Transfer Protein Inhibitor [EPC]
  • Microsomal Triglyceride Transfer Protein Inhibitors [MoA]
  • P-Glycoprotein Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 75929-027 Juxtapid 20 mg Oral Capsule by Pharma Packaging Solutions, LLC Dba Tjoapack LLC
  • 75929-170 Juxtapid 10 mg Oral Capsule by Pharma Packaging Solutions, LLC Dba Tjoapack LLC
  • 75929-172 Juxtapid 30 mg Oral Capsule by Pharma Packaging Solutions, LLC Dba Tjoapack LLC
  • 10122-405 Juxtapid 5 mg Oral Capsule by Chiesi USA, Inc.
  • 10122-410 Juxtapid 10 mg Oral Capsule by Chiesi USA, Inc.
  • 10122-420 Juxtapid 20 mg Oral Capsule by Chiesi USA, Inc.
  • 10122-430 Juxtapid 30 mg Oral Capsule by Chiesi USA, Inc.
  • 76431-105 Juxtapid 5 mg Oral Capsule by Aegerion Pharmaceuticals, Inc.
  • 76431-110 Juxtapid 10 mg Oral Capsule by Aegerion Pharmaceuticals, Inc.
  • 76431-120 Juxtapid 20 mg Oral Capsule by Aegerion Pharmaceuticals, Inc.
  • 76431-130 Juxtapid 30 mg Oral Capsule by Aegerion Pharmaceuticals, Inc.
  • 76431-140 Juxtapid 40 mg Oral Capsule by Aegerion Pharmaceuticals, Inc.
  • 76431-160 Juxtapid 60 mg Oral Capsule by Aegerion Pharmaceuticals, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 75929-243 QR Code

< Prev: 75929-230Next: 75930-001 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.